cancer research technology
Brain Cancer Patients With ‘T allele’ Live 5 Months Longer
The T allele is also predictive of a positive response to the standard cancer treatment, temozolomide.
Clearbridge & LIDE Launch China’s First CTC Hub
Clearbridge Biomedics has partnered LIDE Biotech to bring circulating tumor cell isolation technology to China.
Astellas & Cancer Research UK Team Up In Fight Against Cancer
The partnership between Astellas and Cancer Research Technology will begin with the development of drugs for pancreatic cancer targeting autophagy.





